Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers

Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in c57bl/6j mice.

(2014) Rachel L. Poole et al.   BEHAVIORAL NEUROSCIENCE

Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats

(2014) Alycia M. Lee et al.   BEHAVIOURAL BRAIN RESEARCH

Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal

(2014) Rebecca L Ashare et al.   Expert Opinion on Drug Discovery

Pharmacological Treatments for Smoking Cessation

(2014) Kate Cahill et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Working Memory-Related Neural Activity Predicts Future Smoking Relapse

(2014) James Loughead et al.   NEUROPSYCHOPHARMACOLOGY

Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications

(2013) Kenneth A. Perkins et al.   ADDICTION

Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach

(2013) Bernard Le Foll et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration

(2013) Xiu Liu   PSYCHOPHARMACOLOGY

Discriminative-stimulus effects of NS9283, a nicotinic α4β2* positive allosteric modulator, in nicotine-discriminating rats

(2013) Eric G. Mohler et al.   PSYCHOPHARMACOLOGY

Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats

(2012) Blake A. Kimmey et al.   ADDICTION BIOLOGY

Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study

(2012) Rebecca L. Ashare et al.   DRUG AND ALCOHOL DEPENDENCE

Cognitive enhancement as a treatment for drug addictions

(2012) Mehmet Sofuoglu et al.   NEUROPHARMACOLOGY

Galantamine, an Acetylcholinesterase Inhibitor and Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors, Attenuates Nicotine Taking and Seeking in Rats

(2012) Thomas J Hopkins et al.   NEUROPSYCHOPHARMACOLOGY

Smoking-Attributable Mortality by Cause in the United States: Revising the CDC's Data and Estimates

(2012) B. Rostron   NICOTINE & TOBACCO RESEARCH

Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report

(2012) Mehmet Sofuoglu et al.   PSYCHOPHARMACOLOGY

Reward, Addiction, Withdrawal to Nicotine

(2011) Mariella De Biasi et al.   Annual Review of Neuroscience

Use of Varenicline for 4 Weeks Before Quitting Smoking

(2011) Peter Hajek et al.   ARCHIVES OF INTERNAL MEDICINE

The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice

(2011) Derek S. Wilkinson et al.   BEHAVIOURAL BRAIN RESEARCH

Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior

(2011) Luis M. Tuesta et al.   BIOCHEMICAL PHARMACOLOGY

Lorcaserin, a 5-HT2C Agonist, Decreases Nicotine Self-Administration in Female Rats

(2011) E. D. Levin et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Assessing Recent Smoking Status by Measuring Exhaled Carbon Monoxide Levels

(2011) AnnSofi Sandberg et al.   PLoS One

Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers

(2011) R. De La Garza et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Impact of self-initiated pre-quit smoking reduction on cessation rates: Results of a clinical trial of smoking cessation among female prisoners

(2010) Karen L. Cropsey et al.   ADDICTIVE BEHAVIORS

Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats

(2010) Alessandra Giarola et al.   BEHAVIOURAL PHARMACOLOGY

Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans

(2010) K A Perkins et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

(2010) Martin R. Farlow et al.   CLINICAL THERAPEUTICS

Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats

(2010) C. W. Goh et al.   DRUG METABOLISM AND DISPOSITION

Histamine H1 antagonist treatment with pyrilamine reduces nicotine self-administration in rats

(2010) Edward D. Levin et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism

(2010) M. Giorgetti et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration

(2010) Olivier George et al.   PSYCHOPHARMACOLOGY

Working memory deficits predict short-term smoking resumption following brief abstinence

(2009) Freda Patterson et al.   DRUG AND ALCOHOL DEPENDENCE

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimerʼs Disease

(2009) Stephen Aronson et al.   DRUGS & AGING

Rivastigmine Reduces Tobacco Craving in Alcohol-dependent Smokers

(2009) A. Diehl et al.   PHARMACOPSYCHIATRY

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

(2009) Eoin C. O’Connor et al.   PSYCHOPHARMACOLOGY

Lack of beneficial galantamine effect for smoking behavior: A double-blind randomized trial in people with schizophrenia

(2008) Deanna L. Kelly et al.   SCHIZOPHRENIA RESEARCH

One-week dose titration of extended release galantamine in patients with Alzheimer’s disease

(2007) Douglas W. Scharre et al.   Alzheimers & Dementia